Amgen Set to Buy Onyx Pharmaceuticals

Aug. 26 (Bloomberg) -- Bloomberg’s Drew Armstrong discusses the latest major pharmaceutical deal with Amgen set to purchase Onyx. He speaks with Stephanie Ruhle and Tom Keene on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

There's a Time to Bet on Deutsche Bank... But When?
44:19 - Frederick Lane, managing partner at Lane Generational of Raymond James, discusses the problems at Deutsche Bank, his current investment strategy, and the attractiveness of the U.S. equity market. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • Rebecca Minkoff's Fashionable Aproach to Luxury
  • Market Concerns: Perceived or Real?
  • A Question of Liquidity in European Banking